epilepsy

FDA stop sign

Biotech

FDA places Rapport's nerve damage trial on hold

The FDA has placed a trial of Rapport Therapeutics’ epilepsy drug for a type of nerve pain on hold while the biotech tweaks the study design.

James Waldron Nov 7, 2024 8:50am

doctor examining brain mri scans

Angelini pens $360M biobucks pact for ph. 1 brain disorder drug

Oct 21, 2024 10:04am

graphic of the brain and the electrical signals that make it up

Lundbeck signs $2.5B check for Longboard and its epilepsy med

Oct 14, 2024 8:30am

brain amyloid alzheimers strings detailed web complicated thought

Praxis epilepsy drug reduces seizures in phase 2 trial

Sep 3, 2024 10:21am

good news headline

Addex stock rises after Indivior offers up to $300M for compound

Aug 27, 2024 10:50am

An artists rendition of a seizure in the brain The brain is outlined in neon blue with the overactive neurons in glowing r

Ovid halts preclinical work, IV program after soticlestat fail

Aug 13, 2024 9:15am